185 related articles for article (PubMed ID: 19259799)
1. CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.
Díaz-Benítez CE; Navarro-Fuentes KR; Flores-Sosa JA; Juárez-Díaz J; Uribe-Salas FJ; Román-Basaure E; González-Mena LE; Alonso de Ruíz P; López-Estrada G; Lagunas-Martínez A; Bermúdez-Morales VH; Alcocer-González JM; Martínez-Barnetche J; Hernández-Pando R; Rosenstein Y; Moreno J; Madrid-Marina V
J Clin Immunol; 2009 Jul; 29(4):532-44. PubMed ID: 19259799
[TBL] [Abstract][Full Text] [Related]
2. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
3. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
Xu Q; Wang S; Xi L; Wu S; Chen G; Zhao Y; Wu Y; Ma D
Gynecol Oncol; 2006 Apr; 101(1):132-9. PubMed ID: 16269171
[TBL] [Abstract][Full Text] [Related]
4. Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
de Vos van Steenwijk PJ; Piersma SJ; Welters MJ; van der Hulst JM; Fleuren G; Hellebrekers BW; Kenter GG; van der Burg SH
Clin Cancer Res; 2008 Nov; 14(22):7188-95. PubMed ID: 19010835
[TBL] [Abstract][Full Text] [Related]
5. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
6. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.
Audirac-Chalifour A; Torres-Poveda K; Bahena-Román M; Téllez-Sosa J; Martínez-Barnetche J; Cortina-Ceballos B; López-Estrada G; Delgado-Romero K; Burguete-García AI; Cantú D; García-Carrancá A; Madrid-Marina V
PLoS One; 2016; 11(4):e0153274. PubMed ID: 27115350
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer.
Hou F; Li Z; Ma D; Zhang W; Zhang Y; Zhang T; Kong B; Cui B
Clin Chim Acta; 2012 Nov; 413(23-24):1848-54. PubMed ID: 22820395
[TBL] [Abstract][Full Text] [Related]
8. Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions.
Hubert P; Doyen J; Capelle X; Arafa M; Renoux V; Bisig B; Seidel L; Evrard B; Bousarghin L; Gerday C; Boniver J; Foidart JM; Delvenne P; Jacobs N
Am J Reprod Immunol; 2010 Aug; 64(2):126-36. PubMed ID: 20367631
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Ulchaker J; Panuto J; Rayman P; Novick A; Elson P; Tubbs R; Finke JH; Bukowski RM
J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
[TBL] [Abstract][Full Text] [Related]
11. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
12. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
[TBL] [Abstract][Full Text] [Related]
13. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
Alcocer-González JM; Berumen J; Taméz-Guerra R; Bermúdez-Morales V; Peralta-Zaragoza O; Hernández-Pando R; Moreno J; Gariglio P; Madrid-Marina V
Viral Immunol; 2006; 19(3):481-91. PubMed ID: 16987066
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
Baritaki S; Sifakis S; Huerta-Yepez S; Neonakis IK; Soufla G; Bonavida B; Spandidos DA
Int J Oncol; 2007 Jul; 31(1):69-79. PubMed ID: 17549406
[TBL] [Abstract][Full Text] [Related]
16. Characterization of soluble factors from cultures of premalignant cervical epithelium.
Mota F; Calder V; Rutault K; Singer A; Chain B
Eur J Gynaecol Oncol; 1999; 20(4):262-7. PubMed ID: 10475118
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
[TBL] [Abstract][Full Text] [Related]
18. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
Ahn YO; Lee JC; Sung MW; Heo DS
J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763
[TBL] [Abstract][Full Text] [Related]
19. Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed.
Shibata T; Shah S; Evans T; Coleman H; Lieblong BJ; Spencer HJ; Quick CM; Sasagawa T; Stephens OW; Peterson E; Johann D; Lu YC; Nakagawa M
Front Immunol; 2021; 12():645299. PubMed ID: 34659195
[TBL] [Abstract][Full Text] [Related]
20. Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.
Jacobs N; Giannini SL; Doyen J; Baptista A; Moutschen M; Boniver J; Delvenne P
Clin Exp Immunol; 1998 Jan; 111(1):219-24. PubMed ID: 9472685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
